Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer-Reference-Cited by-同舟云学术

Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer

Published:2008-10 Issue:15 Volume:44 Page:2178-2184
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Bottomley Andrew,Debruyne Channa,Felip Enriqueta,Millward Michael,Thiberville Luc,Addario Giannicola D’,Rome Lisa,Zatloukal Petr,Coens Corneel,Giaccone Giuseppe

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference10 articles.

1. Small cell lung cancer: have we made any progress over the last 25 years?;Lally;Oncologist,2007

2. Phase III study of adjuvant vaccination with Bec2/bacille Calmette–Guerin in responding patients with limited-disease small-cell lung cancer (European organisation for research and treatment of cancer 08971-08971B; silva study);Giaccone;J Clin Oncol,2005

3. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology;Aaronson;J Natl Cancer Inst,1993

4. The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC study group on quality of life;Bergman;Eur J Cancer,1994

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing potential role of gangliosides in immunomodulation and cancer therapeutics;Life Sciences;2024-08

2. Radiotherapy and Immunotherapy in Lung Cancer;Biomedicines;2023-06-06

3. Lung cancer immunotherapy: progress, pitfalls, and promises;Molecular Cancer;2023-02-21

4. Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives;Cancers;2022-01-27

5. Functional nanomaterials and nanocomposite in cancer vaccines;Nanotherapeutics in Cancer Vaccination and Challenges;2022